Eric Wieben

Eric D. Wieben, Ph.D., is a prominent figure in the field of genomics, currently serving as the Director of Genomics Research at Mayo Clinic. He has a robust academic background, having earned his Ph.D. in Biochemistry and Molecular Biology. His research primarily focuses on understanding how changes in gene structure and function impact human health, particularly in the context of individualized medicine.

Professional Background

• Current Role: Dr. Wieben directs the Genome Analysis Core at the Mayo Clinic Comprehensive Cancer Center, which provides essential genomic services including gene expression profiling and genotyping to support cancer research.12
• Expertise: He specializes in advanced genome sequencing technologies that allow for rapid and comprehensive analysis of DNA, facilitating personalized treatment approaches for patients. His work emphasizes the importance of understanding individual genetic variability and its implications for health.25

Contributions to Genomics

Dr. Wieben has significantly contributed to the evolution of genome sequencing methods, advocating for technologies that can sequence long DNA segments more efficiently. This advancement enhances researchers' ability to assemble complete genomic sequences from fragmented data, which is crucial for accurate diagnosis and treatment planning.24

Academic Affiliations

In addition to his directorial role, Dr. Wieben holds a position as Professor Emeritus at Mayo Clinic and has previously served as Chair of the Department of Biochemistry and Molecular Biology. His extensive experience includes leading initiatives that have sequenced vast amounts of DNA, contributing to advancements in genomic medicine.36

Dr. Wieben's work continues to be pivotal in translating genomic research into practical applications that improve patient care, reflecting his commitment to advancing the field of individualized medicine.